Literature DB >> 8755520

DP-2, a heterodimeric partner of E2F: identification and characterization of DP-2 proteins expressed in vivo.

K T Rogers1, P D Higgins, M M Milla, R S Phillips, J M Horowitz.   

Abstract

E2F is a heterodimeric transcription factor that regulates the expression of genes at the G1/S boundary and is composed of two related but distinct families of proteins, E2F and DP. E2F/DP heterodimers form complexes with the retinoblastoma (Rb) protein, the Rb-related proteins p107 and p130, and cyclins/cdks in a cell cycle-dependent fashion in vivo. E2F is encoded by at least five closely related genes, E2F-1 through -5. Here we report studies of DP-2, the second member of the DP family of genes. Our results indicate that (i) DP-2 encodes at least five distinct mRNAs, (ii) a site of alternative splicing occurs within the 5' untranslated region of DP-2 mRNA, (iii) at least three DP-2-related proteins (of 55, 48, and 43 kDa) are expressed in vivo, (iv) each of these proteins is phosphorylated, and (v) one DP-2 protein (43 kDa) carries a truncated amino terminus. Our data also strongly suggest that the 55-kDa DP-2-related protein is a novel DP-2 isoform that results from alternative splicing. Thus, we conclude that DP-2 encodes a set of structurally, and perhaps functionally, distinct proteins in vivo.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8755520      PMCID: PMC38791          DOI: 10.1073/pnas.93.15.7594

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

1.  The T/E1A-binding domain of the retinoblastoma product can interact selectively with a sequence-specific DNA-binding protein.

Authors:  T Chittenden; D M Livingston; W G Kaelin
Journal:  Cell       Date:  1991-06-14       Impact factor: 41.582

2.  The E2F transcription factor is a cellular target for the RB protein.

Authors:  S P Chellappan; S Hiebert; M Mudryj; J M Horowitz; J R Nevins
Journal:  Cell       Date:  1991-06-14       Impact factor: 41.582

3.  Cell cycle regulation of the E2F transcription factor involves an interaction with cyclin A.

Authors:  M Mudryj; S H Devoto; S W Hiebert; T Hunter; J Pines; J R Nevins
Journal:  Cell       Date:  1991-06-28       Impact factor: 41.582

4.  A new member of the DP family, DP-3, with distinct protein products suggests a regulatory role for alternative splicing in the cell cycle transcription factor DRTF1/E2F.

Authors:  E Ormondroyd; S de la Luna; N B La Thangue
Journal:  Oncogene       Date:  1995-10-19       Impact factor: 9.867

5.  Independent binding of the retinoblastoma protein and p107 to the transcription factor E2F.

Authors:  L Cao; B Faha; M Dembski; L H Tsai; E Harlow; N Dyson
Journal:  Nature       Date:  1992-01-09       Impact factor: 49.962

6.  The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner.

Authors:  S Shirodkar; M Ewen; J A DeCaprio; J Morgan; D M Livingston; T Chittenden
Journal:  Cell       Date:  1992-01-10       Impact factor: 41.582

7.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

8.  The retinoblastoma protein copurifies with E2F-I, an E1A-regulated inhibitor of the transcription factor E2F.

Authors:  S Bagchi; R Weinmann; P Raychaudhuri
Journal:  Cell       Date:  1991-06-14       Impact factor: 41.582

9.  A cyclin A-protein kinase complex possesses sequence-specific DNA binding activity: p33cdk2 is a component of the E2F-cyclin A complex.

Authors:  S H Devoto; M Mudryj; J Pines; T Hunter; J R Nevins
Journal:  Cell       Date:  1992-01-10       Impact factor: 41.582

10.  Cyclin A and the retinoblastoma gene product complex with a common transcription factor.

Authors:  L R Bandara; J P Adamczewski; T Hunt; N B La Thangue
Journal:  Nature       Date:  1991-07-18       Impact factor: 49.962

View more
  13 in total

1.  Distinct cellular factors regulate the c-myb promoter through its E2F element.

Authors:  M R Campanero; M Armstrong; E Flemington
Journal:  Mol Cell Biol       Date:  1999-12       Impact factor: 4.272

2.  Genome-wide analysis of core cell cycle genes in Arabidopsis.

Authors:  Klaas Vandepoele; Jeroen Raes; Lieven De Veylder; Pierre Rouzé; Stephane Rombauts; Dirk Inzé
Journal:  Plant Cell       Date:  2002-04       Impact factor: 11.277

3.  Integration of a growth-suppressing BTB/POZ domain protein with the DP component of the E2F transcription factor.

Authors:  S de la Luna; K E Allen; S L Mason; N B La Thangue
Journal:  EMBO J       Date:  1999-01-04       Impact factor: 11.598

4.  Subunit composition determines E2F DNA-binding site specificity.

Authors:  Y Tao; R F Kassatly; W D Cress; J M Horowitz
Journal:  Mol Cell Biol       Date:  1997-12       Impact factor: 4.272

5.  Global analysis of induced transcription factors and cofactors identifies Tfdp2 as an essential coregulator during terminal erythropoiesis.

Authors:  Cynthia Chen; Harvey F Lodish
Journal:  Exp Hematol       Date:  2014-03-07       Impact factor: 3.084

6.  E2F1 and E2F2 have opposite effects on radiation-induced p53-independent apoptosis in Drosophila.

Authors:  Anita Wichmann; Lyle Uyetake; Tin Tin Su
Journal:  Dev Biol       Date:  2010-07-24       Impact factor: 3.582

Review 7.  E2F transcription factors and digestive system malignancies: how much do we know?

Authors:  Athanasios Xanthoulis; Dina G Tiniakos
Journal:  World J Gastroenterol       Date:  2013-06-07       Impact factor: 5.742

Review 8.  Small molecule regulators of Rb-E2F pathway as modulators of transcription.

Authors:  Sandeep Singh; Jackie Johnson; Srikumar Chellappan
Journal:  Biochim Biophys Acta       Date:  2010-07-15

9.  Molecular cloning and expression pattern of the DP members of the chicken E2F transcription factor.

Authors:  L Loiseau; S Pasteau; G Brun
Journal:  Gene Expr       Date:  1997

10.  14-3-3 proteins integrate E2F activity with the DNA damage response.

Authors:  Alasdair H Milton; Nandkumar Khaire; Laura Ingram; Amanda J O'Donnell; Nicholas B La Thangue
Journal:  EMBO J       Date:  2006-02-16       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.